Hepion Pharmaceuticals Stock Shares Outstanding
| HEPA Stock | USD 1.30 0.06 4.84% |
Hepion Pharmaceuticals fundamentals help investors to digest information that contributes to Hepion Pharmaceuticals' financial success or failures. It also enables traders to predict the movement of Hepion Stock. The fundamental analysis module provides a way to measure Hepion Pharmaceuticals' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Hepion Pharmaceuticals stock.
The current year's Common Stock Shares Outstanding is expected to grow to about 4.2 M. Hepion | Shares Outstanding |
Hepion Pharmaceuticals Company Shares Outstanding Analysis
Hepion Pharmaceuticals' Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Current Hepion Pharmaceuticals Shares Outstanding | 5.47 M |
Most of Hepion Pharmaceuticals' fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Hepion Pharmaceuticals is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Hepion Shares Outstanding Driver Correlations
Understanding the fundamental principles of building solid financial models for Hepion Pharmaceuticals is extremely important. It helps to project a fair market value of Hepion Stock properly, considering its historical fundamentals such as Shares Outstanding. Since Hepion Pharmaceuticals' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Hepion Pharmaceuticals' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Hepion Pharmaceuticals' interrelated accounts and indicators.
Click cells to compare fundamentals
Hepion Shares Outstanding Historical Pattern
Today, most investors in Hepion Pharmaceuticals Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Hepion Pharmaceuticals' growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's shares outstanding growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Hepion Pharmaceuticals shares outstanding as a starting point in their analysis.
Hepion Pharmaceuticals Shares Outstanding |
| Timeline |
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
| Competition |
Hepion Common Stock Shares Outstanding
Common Stock Shares Outstanding |
|
Based on the latest financial disclosure, Hepion Pharmaceuticals has 5.47 M of shares currently outstending. This is 96.97% lower than that of the Pharmaceuticals sector and 94.88% lower than that of the Health Care industry. The shares outstanding for all United States stocks is 99.04% higher than that of the company.
Hepion Shares Outstanding Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Hepion Pharmaceuticals' direct or indirect competition against its Shares Outstanding to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Hepion Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Hepion Pharmaceuticals by comparing valuation metrics of similar companies.Hepion Pharmaceuticals is currently under evaluation in shares outstanding category among related companies.
Hepion Pharmaceuticals Current Valuation Drivers
We derive many important indicators used in calculating different scores of Hepion Pharmaceuticals from analyzing Hepion Pharmaceuticals' financial statements. These drivers represent accounts that assess Hepion Pharmaceuticals' ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Hepion Pharmaceuticals' important valuation drivers and their relationship over time.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Market Cap | 11.0M | 21.2M | 80.1M | 12.9M | 11.6M | 20.6M | |
| Enterprise Value | (2.2M) | (18.8M) | (10.9M) | (1.7M) | (2.0M) | (2.1M) |
Hepion Fundamentals
| Return On Equity | -1.71 | ||||
| Return On Asset | -0.72 | ||||
| Current Valuation | (5.77 M) | ||||
| Shares Outstanding | 5.47 M | ||||
| Shares Owned By Insiders | 0.30 % | ||||
| Shares Owned By Institutions | 13.24 % | ||||
| Number Of Shares Shorted | 63.89 K | ||||
| Price To Earning | (3.01) X | ||||
| Price To Book | 0.67 X | ||||
| EBITDA | (45.19 M) | ||||
| Net Income | (48.93 M) | ||||
| Cash And Equivalents | 59.15 M | ||||
| Cash Per Share | 0.78 X | ||||
| Total Debt | 209.02 K | ||||
| Debt To Equity | 0 % | ||||
| Current Ratio | 8.77 X | ||||
| Book Value Per Share | 1.16 X | ||||
| Cash Flow From Operations | (40.89 M) | ||||
| Short Ratio | 1.22 X | ||||
| Earnings Per Share | (12.32) X | ||||
| Target Price | 26.0 | ||||
| Number Of Employees | 22 | ||||
| Beta | 1.72 | ||||
| Market Capitalization | 7.11 M | ||||
| Total Asset | 18.09 M | ||||
| Retained Earnings | (224.63 M) | ||||
| Working Capital | 12.2 M | ||||
| Current Asset | 4.82 M | ||||
| Current Liabilities | 1.81 M | ||||
| Net Asset | 18.09 M |
About Hepion Pharmaceuticals Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Hepion Pharmaceuticals's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Hepion Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Hepion Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Hepion Pharmaceuticals offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Hepion Pharmaceuticals' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Hepion Pharmaceuticals Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Hepion Pharmaceuticals Stock:Check out Hepion Pharmaceuticals Piotroski F Score and Hepion Pharmaceuticals Altman Z Score analysis. For information on how to trade Hepion Stock refer to our How to Trade Hepion Stock guide.You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Complementary Tools for Hepion Stock analysis
When running Hepion Pharmaceuticals' price analysis, check to measure Hepion Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Hepion Pharmaceuticals is operating at the current time. Most of Hepion Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Hepion Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Hepion Pharmaceuticals' price. Additionally, you may evaluate how the addition of Hepion Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm |
Is Hepion Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Hepion Pharmaceuticals. If investors know Hepion will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Hepion Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (12.32) | Return On Assets (0.72) | Return On Equity (1.71) |
The market value of Hepion Pharmaceuticals is measured differently than its book value, which is the value of Hepion that is recorded on the company's balance sheet. Investors also form their own opinion of Hepion Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Hepion Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Hepion Pharmaceuticals' market value can be influenced by many factors that don't directly affect Hepion Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Hepion Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Hepion Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Hepion Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.